BeOne Medicines (ONC) shares outstanding: 1.48B
BeOne Medicines had 1.48B shares outstanding on Oct 30, 2026, up 3.2% from 1.44B a year earlier.
From BeOne Medicines's filings with the SEC · ONC stock page
BeOne Medicines shares outstanding by year
#57 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 30, 2026 | 1.48B | +3% |
| Nov 1, 2025 | 1.44B | +4% |
| Nov 1, 2024 | 1.39B | +2% |
| Nov 1, 2023 | 1.36B | +1% |
| Oct 31, 2022 | 1.35B | – |
Shares outstanding of similar companies
Companies in the same industry as BeOne Medicines, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Bristol Myers Squibb | 2.04B | Oct 21, 2026 |
| AbbVie | 1.77B | Oct 26, 2026 |
| Abbott Laboratories | 1.73B | Sep 30, 2026 |
| BeOne Medicines | 1.48B | Oct 30, 2026 |
| TEVA Pharmaceutical Industries | 1.17B | Sep 30, 2026 |
| Viatris | 1.15B | Nov 2, 2026 |
| Eli Lilly | 940.7M | Oct 26, 2026 |
Questions and answers
What is BeOne Medicines's shares outstanding?
BeOne Medicines had 1.48B shares outstanding on Oct 30, 2026, up 3.2% from 1.44B a year earlier.
Numbers as reported in BeOne Medicines's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology